Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret A Nagai-Singer

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Advances in Nutrition (Bethesda, Md.)|December 4, 2025
The Role of Dietary Supplements in Environmental ChallengesMargaret A Nagai-Singer, Jun Wu
Molecular Aspects of Medicine|May 4, 2020
To protect or adversely affect? The dichotomous role of the NLRP1 inflammasome in human diseaseJuselyn D Tupik, Margaret A Nagai-Singer, Irving C Allen
Frontiers in Immunology|November 5, 2019
NLRX1 Is a Multifaceted and Enigmatic Regulator of Immune System FunctionMargaret A Nagai-Singer, Holly A Morrison, Irving C Allen
JAMA Network Open|February 11, 2025
Prepandemic Prevalence of Dietary Supplement Use for Immune BenefitsMargaret A Nagai-Singer, Edwina A Wambogo, Stefan M Pasiakos, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 30, 2022
Employing Novel Porcine Models of Subcutaneous Pancreatic Cancer to Evaluate Oncological TherapiesAlissa Hendricks-Wenger, Margaret A Nagai-Singer, Kyungjun Uh, et al.
Methods in Cell Biology|April 3, 2022
Methods to evaluate virus-mediated acute lung inflammationHannah M Ivester, Juselyn D Tupik, Margaret A Nagai-Singer, et al.
Frontiers in Immunology|May 16, 2022
NLRX1 Deficiency Alters the Gut Microbiome and Is Further Exacerbated by Adherence to a Gluten-Free DietHolly A Morrison, Yang Liu, Kristin Eden, et al.
Frontiers in Oncology|April 4, 2022
Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic CancerKhan Mohammad Imran, Margaret A Nagai-Singer, Rebecca M Brock, et al.
Veterinary Pathology|March 11, 2021
Evaluation of Myogenin and MyoD1 as Immunohistochemical Markers of Canine RhabdomyosarcomaJoanne L Tuohy, Brittney J Byer, Suzanne Royer, et al.
Frontiers in Oncology|June 21, 2023
NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cellsMargaret A Nagai-Singer, Holly A Morrison, Mackenzie K Woolls, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Advances in Nutrition (Bethesda, Md.)|December 4, 2025
The Role of Dietary Supplements in Environmental ChallengesMargaret A Nagai-Singer, Jun Wu
Molecular Aspects of Medicine|May 4, 2020
To protect or adversely affect? The dichotomous role of the NLRP1 inflammasome in human diseaseJuselyn D Tupik, Margaret A Nagai-Singer, Irving C Allen
Frontiers in Immunology|November 5, 2019
NLRX1 Is a Multifaceted and Enigmatic Regulator of Immune System FunctionMargaret A Nagai-Singer, Holly A Morrison, Irving C Allen
JAMA Network Open|February 11, 2025
Prepandemic Prevalence of Dietary Supplement Use for Immune BenefitsMargaret A Nagai-Singer, Edwina A Wambogo, Stefan M Pasiakos, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 30, 2022
Employing Novel Porcine Models of Subcutaneous Pancreatic Cancer to Evaluate Oncological TherapiesAlissa Hendricks-Wenger, Margaret A Nagai-Singer, Kyungjun Uh, et al.
Methods in Cell Biology|April 3, 2022
Methods to evaluate virus-mediated acute lung inflammationHannah M Ivester, Juselyn D Tupik, Margaret A Nagai-Singer, et al.
Frontiers in Immunology|May 16, 2022
NLRX1 Deficiency Alters the Gut Microbiome and Is Further Exacerbated by Adherence to a Gluten-Free DietHolly A Morrison, Yang Liu, Kristin Eden, et al.
Frontiers in Oncology|April 4, 2022
Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic CancerKhan Mohammad Imran, Margaret A Nagai-Singer, Rebecca M Brock, et al.
Veterinary Pathology|March 11, 2021
Evaluation of Myogenin and MyoD1 as Immunohistochemical Markers of Canine RhabdomyosarcomaJoanne L Tuohy, Brittney J Byer, Suzanne Royer, et al.
Frontiers in Oncology|June 21, 2023
NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cellsMargaret A Nagai-Singer, Holly A Morrison, Mackenzie K Woolls, et al.
Pageof 2